June 26, 2019
Ono Pharmaceutical has acquired exclusive rights in Japan and some other Asian markets for US biotech Rafael Pharmaceuticals’ metabolic cancer drug devimistat and related compounds, the two companies said on June 25. Under the deal, Ono will exclusively develop and...read more